Sunshine Biopharma, Inc. Announces Board Changes
next annual meeting of shareholders, his resignation, removal or death, whichever comes first. In addition to Merzouki, new positions with company, since January 2015 he has been self- employed as a consultant in the fields of biotechnology and pharmacology. From July 2007 through December 2014, Dr. Merzouki worked at the Institute of Biomedical Engineering in the Department of Chemical Engineering at Ecole Polytechnique de Montreal.